Immunotherapy targeting tumor-associated antigen in a mouse model of head and neck cancer.
Michihisa KonoRisa WakisakaHiroki KomatsudaRyusuke HayashiTakumi KumaiHidekiyo YamakiRyosuke SatoToshihiro NagatoTakayuki OhkuriAkemi KosakaKenzo OharaKan KishibeHiroya KobayashiTatsuya HayashiMiki TakaharaPublished in: Head & neck (2024)
We demonstrated that novel c-Met peptide vaccines can induce antitumor T-cell response, and could be a potent immunotherapy in a syngeneic mouse HNSCC model.